On the forefront of healthcare change to turn innovative science into value for patients.
To better explore cutting-edge science and technology, and to uncover new insights that have the potential to transform what we know and bring to life the results of our R&D efforts, we’ve undertaken various initiatives such as:
Under the Network Research System based on the concept of “best science, best talent, best place”, we build partnerships with external researchers and companies that complement our existing expertise, enabling us to quickly advance into new technologies and therapeutic areas of research that may help more people sooner.
The FASTEN (FAST–Ex-New-Standards) initiative sets criteria that enable us to optimize resource allocation and the acquisition of cutting-edge science, which helps us shorten R&D duration and increase cost efficiency.
Through these initiatives Astellas is driving ceaseless innovation by enhancing its capability to deliver innovative medicines and continuously advancing new opportunities.
NPR/18/0046/APEL. February 2019